secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2026-02-23T23:59:59+00:00
Accession:  0001193125-26-064291
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC files new $200M ATM offering; prior program fully utilized
---------------------------------------------------------------

- New prospectus supplement filed Feb 26, 2026 for up to $200M in shares via Jefferies.
- Prior $200M program (2024) terminated after raising $139.7M gross from 13.48M shares.
- No further sales will be made under the 2024 prospectus supplement.
- Legal opinion from Wilson Sonsini filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312526064291/0001193125-26-064291-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312526064291/d25338d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-064291

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer